Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4631819 | 0.76 | TSHR (0.43) | TSHRACHEPPARDMAPTHTT | |
| SCHEMBL15367919 | 0.74 | TSHR (0.50) | TSHRPPARDMAPTHTTTP53 | |
| SCHEMBL10041879 | 0.72 | TSHR (0.48) | TSHRPPARDMAPTHTTTP53 | |
| SCHEMBL6311761 | 0.72 | TSHR (0.48) | TSHRPPARDMAPTHTTTP53 | |
| SCHEMBL5411879 | 0.72 | ALDH1A1 (0.31) | TSHRALDH1A1 | |
| SCHEMBL8611627 | 0.72 | TSHR (0.39) | TSHRMAPTL3MBTL1LMNAALDH1A1 | |
| SCHEMBL517580 | 0.71 | TSHR (0.46) | TSHRPPARDMAPTHTTTP53 | |
| SCHEMBL10013495 | 0.71 | TSHR (0.46) | TSHRPPARDMAPTHTTTP53 | |
| SCHEMBL13421215 | 0.71 | TSHR (0.46) | TSHRPPARDMAPTHTTTP53 | |
| SCHEMBL4633658 | 0.71 | TSHR (0.41) | TSHRACHEPPARDMAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7311860-B2 | 1,3,5-tricyano-2,4,6-tris(vinyl)benzene derivatives and method for preparing the same | KOREA UNIVERSITY FOUNDATION (KR) | 2007-12-25 | — | — | US | disclosed |
| US-7311860-B2 | 1,3,5-tricyano-2,4,6-tris(vinyl)benzene derivatives and method for preparing the same | KOREA UNIVERSITY FOUNDATION (KR) | 2007-12-25 | — | — | US | disclosed |
| US-20040251452-A1 | 1,3,5-Tricyano-2,4,6-tris(vinyl)benzene derivatives and method for preparing the same | SFC CO., LTD. (KR) | 2004-12-16 | — | — | US | disclosed |
| US-20040251452-A1 | 1,3,5-Tricyano-2,4,6-tris(vinyl)benzene derivatives and method for preparing the same | SFC CO., LTD. (KR) | 2004-12-16 | — | — | US | disclosed |
| WO-2003011817-A1 | 1, 3, 5-TRICYANO-2, 4, 6-TRIS(VINYL)BENZENE DERIVATIVES AND METHOD FOR PREPARING THE SAME | KOREA UNIVERSITY FOUNDATION (KR) | 2003-02-13 | — | — | WO | disclosed |
| WO-2003011817-A1 | 1, 3, 5-TRICYANO-2, 4, 6-TRIS(VINYL)BENZENE DERIVATIVES AND METHOD FOR PREPARING THE SAME | KOREA UNIVERSITY FOUNDATION (KR) | 2003-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040251452-A1 | 1,3,5-Tricyano-2,4,6-tris(vinyl)benzene derivatives and method for preparing the same | TDO2, TRPV6, TRPC6 | TSHR 1557/4885ACHE 2367/4885PPARD 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.